Galectin-3 (Gal-3) has emerged as an important biomarker due to its key role in cardiac remodeling and heart failure alongside NT-proBNP and BNP, which was demonstrated in a recent meta-analysis ​ [5], and more recently in PE [6]. Here, LGALS3 is linked to heart failure.